Prescription Drug Monitoring Program (216-RICR-20-20-3)

216-RICR-20-20-3 PROPOSED RULE

Title 216 Department of Health
Chapter 20 Community Health
Subchapter 20 Drugs
Part 3 Prescription Drug Monitoring Program (216-RICR-20-20-3)
Type of Filing Amendment
Regulation Status Proposed
Filing Notice Date 12/30/2024
Public Comment Dates 12/30/2024 to 01/29/2025

Regulation Authority:

R.I. Gen. Laws § § 21-28-3.18(d)(2) and 21-28-3.32(n)(3

Purpose and Reason:

RIDOH is proposing the following amendments to Prescription Drug Monitoring Program (216-RICR-20-20-3):

  • Removing the list of required information to be transmitted to RIDOH by a pharmacy and signposting to the statutory requirements;
  • Adding the Medical Director of a practice as an individual authorized to access the information in the PDMP as required by the statute; and,
  • Correcting minor drafting errors.

0

Comment(s) Received*

The agency is not accepting online public comments for this filing.To submit a comment, please contact the agency directly at the addresses listed on the Notice of Proposed Rulemaking.

* This count refers to the total comment submissions received on this document, as of 11:59 PM yesterday.
Note: Agencies review all submissions; however, some agencies may choose to withhold certain submissions such as those containing private or sensitive information, profane or threatening language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and the actual number of comments displayed on this page. For specific information about a comment you submitted, please contact the agency directly.


Home
RICR FAQs

Search Regulations